Skip To Main Content
Steven Gitelis on Muck Rack

Steven Gitelis

As seen in: Nature, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Steven Gitelis’s profile

Articles by Steven Gitelis

Safety and efficacy of lacnotuzumab, a colony-stimulating factor 1 antibody for the treatment of tenosynovial giant cell tumors: a randomized phase II trial

|
By Edward P. Cheng, Ursula Schramm, Alireza Mirzaei, Franziska Saxer, Didier Laurent, Thomas Peters, Marie-Anne Valentin, Jens Praestgaard, Heng Zou, John Abraham, Joel Block, Steven Gitelis, Robert Henshaw, Breelyn Wilky, Andreas Krieg, Jonathan C. Trent, Ronenn Roubenoff, Matthias Schieker, Romana Lowcock, Marion Wiesmann, Pascale Pinot, Marta Batus, Anna A. Khachatrian, Hiram F. Correa, Evan Beckmann
| Nature Verified
Abstract Tenosynovial giant cell tumors (TGCT) are locally aggressive tumors that are often difficult to treat surgically due to their size and diffuse growth. Systemic therapies targeting the colony-stimulating factor-1 (CSF-1) pathway have emerged as alternatives. This study assessed the safety and efficacy of lacnotuzumab, a monoclonal antibody against CSF-1.
Open in Who Shared Issue with article?

The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer

|
By Taisen Zhuang, Aviram Nissan, Jerome Canady, Steven Gitelis
| MDPI
4. Discussion The LRR rate for solid tumors remains as high as 65%, even in the absence of distant disease [4]. Historically, stage IV solid tumors are typically not resected due to the high risk of palliative surgery [35]. We demonstrated that CHCP treatment in combination with surgery is a viable option for controlling LRR and possibly improving overall survival. CHCP is a safe and potentially effective treatment option for a wide range of Stage IV or Recurrent solid tumors.
Open in Who Shared Issue with article?
Show More